December 8th, 2011

Actos® Suits Increasing Dramatically

By Greg Webb

Takeda Pharmaceutical Co., the Japanese drug company, is being sued by more Actos® users whose treatment for diabetes may cause bladder cancer, but marketing of Actos continues in the U.S. Weitz & Luxemberg attorney Paul J. Pennock noted his firm represents 1,200 former Actos users, and he expected the number of lawsuits could rise to 10,000 due to the effects of Actos on people whose diabetes has been treated with the drug. In June 2011, Germany joined France in suspending the top-selling Takeda drug, Actos in their markets, whose sales topped $4.8 billion so far this fiscal year, due to the threat of bladder cancer occurring in its users.

Read more:


Add your own Comment